73MO Sotorasib (soto), panitumumab (pani), and FOLFIRI in first-line (1L) KRAS G12C–mutated metastatic colorectal cancer (mCRC): Regional analysis of safety and efficacy from CodeBreaK 101.

Authors :: Masuishi, T.
Yamaguchi, K.
Rodriguez, J.C. Ruffinelli
Corral de la Fuente, E.
Kuboki, Y.
Cremolini, C.
Ruiz, I. Victoria
Fernandez, M.E. Elez
Strickler, J.H.
Furqan, M.
Bashir, B.
Nduka, C.
Hippenmeyer, J.
Chan, E.
Xia, C.
Siena, S.
Source :: Annals of Oncology. 2024 Supplement 4, Vol. 35, pS1432-S1432. 1p.
Publication Year :: 2024

Subjects :: *COLORECTAL cancer
*PANITUMUMAB
*METASTASIS
*CANCER chemotherapy

Full Text Access

Tools